Blog
RSS FeedPosted by Michael Wonder on 22 May 2019
Guyon Espiner investigates PHARMAC: The NZ Buyer’s Club
23 May 2019 - Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders ...
Posted by Michael Wonder on 20 May 2019
Theresa May urges US makers of cystic fibrosis drug to strike ‘crucial’ deal with NHS
17 May 2019 - Theresa May last night urged US makers of a drug that prolongs life for cystic fibrosis sufferers ...
Posted by Michael Wonder on 20 May 2019
Europe responding to gene therapy challenge, but picture remains fragmented
20 May 2019 - Germany, Italy and England using outcomes-based deals. ...
Posted by Michael Wonder on 20 May 2019
Trump administration postpones some Medicare drug cost proposals
17 May 2019 - The administration says it will not give health plans the authority to negotiate pricing for certain drugs ...
Posted by Michael Wonder on 20 May 2019
UCB announces Nayzilam (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the US
19 May 2019 - Nayzilam allows for administration by a non-healthcare professional in patients actively seizing when and where a seizure ...
Posted by Michael Wonder on 20 May 2019
ICER plans cloud-based tools to accelerate the use of value assessments in the US health care system
20 May 2019 - With a late 2019 launch target, ICER’s Evidence Compendium and Interactive Modeler will enable decision-makers within payers, ...
Posted by Michael Wonder on 20 May 2019
Korean Government to reduce biopharmaceutical approval period to half
20 May 2019 - The Korean government plans to reduce by half the current one and a half years of ...
Posted by Michael Wonder on 20 May 2019
Health Technology Assessment Consumer Consultative Committee March 2019 meeting communiqué
20 May 2019 - A communiqué from the March 2019 meeting of the HTA Consumer Consultative Committee has been published. ...
Posted by Michael Wonder on 20 May 2019
PBS Pharmaceuticals in Hospitals Review
20 May 2019 - The Department of Health completed the PBS Pharmaceuticals in Hospitals Review to better understand how PBS medicines ...
Posted by Michael Wonder on 20 May 2019
FDA's strengthened global inspection program helps ensure generic drug safety
17 May 2019 - Consumers must have confidence in the safety and quality of generic medicines. ...
Posted by Michael Wonder on 19 May 2019
Trump Administration caves to pharma on Medicare Part D 'protected classes' reform
17 May 2019 - The Trump administration has shelved a proposal that would have stymied egregious price hikes in the ...
Posted by Michael Wonder on 19 May 2019
Gilead’s $21,000 drug is being blamed for a plateau in HIV prevention
17 May 2019 - AIDS activists, CEO O’Day square off at congressional hearing. ...
Posted by Michael Wonder on 19 May 2019
San Francisco, Santa Clara, Alameda counties join Governor Newsom to lower drug prices
16 May 2019 - San Francisco, Santa Clara and Alameda counties joined on Thursday Governor Gavin Newsom’s ambitious plan to ...
Posted by Michael Wonder on 19 May 2019
Trump administration backs off Medicare drug pricing rule
16 May 2019 - The Trump administration on Thursday backed off a controversial Medicare drug pricing proposal that would have ...
Posted by Michael Wonder on 19 May 2019
House passes legislation aiming to shore up health law and lower drug costs
16 May 2019 - The House on Thursday passed a suite of health care bills that tied shoring up the ...
Posted by Michael Wonder on 19 May 2019
Push for drug pricing transparency strikes a nerve with industry
19 May 2019 - Ahead of the World Health Assembly in Geneva, an Italian draft resolution to end secrecy around ...